Discussions

Obesity has evolved into a global problem. It is associated with a wide range of chronic diseases, such as osteoarthritis, sleep apnea, gallstones, fatty liver, hypertension, diabetes, and certain cancers. Although several therapies have been used to treat obesity, many of the approved and marketed anti-obesity drugs have been withdrawn due to serious side effects. Therefore, the necessary safety assessment is a critical step in Preclinical Studies of Anti-Obesity Therapeutics. Protheragen provides high-quality Obesity Models for Pharmacodynamic Study, Pharmacokinetic Study, Bioanalysis, and safety assessment.

web: Safety Assessment of Anti-Obesity Therapeutics